Pharmaco-invasive Therapy: A Continued Role for Fibrinolysis in the Primary PCI era.
Salma BouyaddidAmine BouchlarhemZakaria BazidNabila IsmailiNoha El OuafiPublished in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2023)
The PI-strategy remains a reasonable alternative for pPCI when the latter is not available, with a prognosis almost identical to pPCI in the long term whenever patients are treated early after the onset of symptoms.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- coronary artery disease
- peritoneal dialysis
- acute myocardial infarction
- prognostic factors
- percutaneous coronary intervention
- patient reported outcomes
- antiplatelet therapy
- mesenchymal stem cells
- physical activity
- atrial fibrillation
- st segment elevation myocardial infarction
- sleep quality
- replacement therapy